Mechanism of Action of Gonadotropin‐releasing Hormone‐stimulated Leydig Cell Steroidogenesis.
Open Access
- 6 May 1984
- journal article
- research article
- Published by Wiley in Journal of Andrology
- Vol. 5 (3) , 193-200
- https://doi.org/10.1002/j.1939-4640.1984.tb02392.x
Abstract
The present study was designed to elucidate mechanisms responsible for gonadotropin‐releasing hormone (GnRH)‐stimulated testosterone formation. Purified Leydig cells from adult Sprague—Dawley rats were incubated with varying concentrations of GnRH agonist (des‐Gly10, (D‐Ala6) GnRH N‐ethylamide), hCG, 8‐bromo cAMP or pregnenolone; testosterone, cAMP, cyclic GMP (cGMP) and cAMP‐dependent protein kinase activity were measured after various time periods. Basal testosterone levels were 2.54 ± 0.13 ng/105 cells, increasing to 3.18 ± 0.14, 4.32 ± 0.08, and 4.63 ± 0.12 ng within 1 hour after the addition of 10−9, 10−8, and 10−7 M GnRH agonist, respectively. After a 3‐hour incubation a 10−7 M dose of GnRH agonist increased testosterone production four‐fold above control. GnRH agonist potentiated hCG‐stimulated testosterone formation, but had no significant effects on cGMP levels and cAMP‐dependent protein kinase activity. Cyclic AMP levels in the incubation medium increased slightly. GnRH agonist also enhanced 8‐bromo‐cAMP and pregnenolone‐induced testosterone formation. Furthermore, GnRH agonist increased testosterone formation both in the absence and presence of phosphodiesterase inhibitor. These results suggest that the major effect of GnRH agonist is probably beyond the cAMP step. When purified Leydig cells were incubated in a calcium‐free medium, the stimulatory effects of GnRH agonist on testosterone formation were completely abolished, but could be restored by the addition of calcium to the incubation medium. GnRH agonist‐induced testosterone formation was also blocked by the addition of nifedipine (a calcium channel blocking agent, 0.1 to 10 μg/ml). Finally, GnRH antagonist in a concentration of 10 μg/ml completely inhibited GnRH agonist‐stimulated testosterone formation. In conclusion: GnRH agonist stimulated Leydig cell testosterone formation in short‐term incubations. The stimulatory effect is calcium dependent and not mediated by cyclic nucleotides.Keywords
This publication has 40 references indexed in Scilit:
- Induction of Puberty in Men by Long-Term Pulsatile Administration of Low-Dose Gonadotropin-Releasing HormoneNew England Journal of Medicine, 1982
- Stimulation and inhibition by LHRH analogues of cultured rat Leydig cell function and lack of effect on mouse Leydig cellsMolecular and Cellular Endocrinology, 1982
- Regulation of Cyclic Guanosine 3′,5′-Monophosphate in Interstitial Cells of the Rat TestisHormone and Metabolic Research, 1981
- Leydig cell receptors for luteinizing hormone releasing hormone and its agonists and their modulation by administration or deprivation of the releasing hormoneBiochemical and Biophysical Research Communications, 1980
- An LHRH agonist inhibits FSH-induced cyclic AMP accumulation and steroidogenesis in porcine granulosa cells in cultureBiochemical and Biophysical Research Communications, 1980
- Reduction of testicular Luteinizing Hormone/Human Chorionic Gonadotropin receptors by [D-Trp6]-Luteinizing Hormone Releasing Hormone in hypophysectomized ratsBiochemical and Biophysical Research Communications, 1979
- Effect of an antagonistic analog of gonadotropin releasing hormone upon ovarian granulosa cell functionLife Sciences, 1979
- Regulation of luteinizing hormone receptors in testicular interstitial cells by gonadotropinBiochemical and Biophysical Research Communications, 1976
- Inositol phospholipids and cell surface receptor functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1975
- Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine originBiochemical and Biophysical Research Communications, 1971